Insights Careers Contact us

Enrollment is where cancer trials are won or lost.

We build recruitment strategy for academic cancer centers. Our focus is the studies that are hardest to fill and the patients research has long struggled to reach.

Enrollment Diagnostics

We find exactly where accrual breaks, from screening to referral to eligibility.

Protocol & Feasibility

We review eligibility for the quiet criteria that shrink your pool before you start.

Site & Referral Enablement

We build the internal and community pathways that surface eligible patients earlier.

Inclusive Enrollment

We reach the patients oncology trials miss, and treat it as part of the science.

Data and insights

Every recruitment decision rests on your own accrual data.

We map the path from eligible patient to enrolled participant, find the stage that is leaking, and rebuild it. Then we track it so a slowdown shows up early instead of at the interim review.

Enrollment funnelwhere studies lose patients
Eligible patients 100% Screened 55% Consented 28% Enrolled 15%

Illustrative. We map real drop-off for each study.

Our mission

We help cancer centers enroll the patients their trials need, and do it faster.

Recruitment is the most common reason a trial misses its timeline, and the most fixable. We bring recruitment strategy that has already moved accrual inside real oncology and genitourinary studies, and put it to work at your center.

Who we serve

Expertise across the cancer research ecosystem

Academic Cancer Centers

Diagnose stalled accrual and rebuild the recruitment strategy behind it.

Research Sites

Tighten the coordinator workflow that decides whether eligible patients enroll.

Principal Investigators

Give a struggling study a clear, measurable path back to its target.

Sponsors

Improve site level accrual on the oncology and GU trials that are hardest to fill.

Track record

Built on recruitment work that has already moved accrual.

40%
faster time to study activation, achieved by our principal in prior trial start-up work
15 yrs
in clinical research, nine of them concentrated in oncology and genitourinary trials
Peer reviewed
published and presented, including ASCO GU, on trial recruitment and outcomes

Tell us which trial is behind.

Start with one study that is not accruing the way it should. We will tell you what we would look at first. No engagement required to have the conversation.